Attached files
| file | filename |
|---|---|
| EX-31.1 - EXHIBIT 31.1 - Pacira BioSciences, Inc. | pcrx-12312015xex311.htm |
| EX-32.2 - EXHIBIT 32.2 - Pacira BioSciences, Inc. | pcrx-12312015xex322.htm |
| EX-32.1 - EXHIBIT 32.1 - Pacira BioSciences, Inc. | pcrx-12312015xex321.htm |
| EX-31.2 - EXHIBIT 31.2 - Pacira BioSciences, Inc. | pcrx-12312015xex312.htm |
| EX-21.1 - EXHIBIT 21.1 - Pacira BioSciences, Inc. | pcrx-12312015xex211.htm |
| EX-10.57 - EXHIBIT 10.57 - Pacira BioSciences, Inc. | pcrx-12312015xex1057.htm |
| 10-K - 10-K - Pacira BioSciences, Inc. | pcrx-12312015x10k.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in Registration Statement Nos. 333-175101, 333-181986 and 333-196542 on Form S-8 and Registration Statement No. 333-195099 on Form S-3 of our report dated February 25, 2016, on our audits of the consolidated financial statements of Pacira Pharmaceuticals, Inc. and Subsidiaries as of December 31, 2015 and 2014, and for each of the three years in the period ended December 31, 2015 and our report on our audit of the internal control over financial reporting of Pacira Pharmaceuticals, Inc. and Subsidiaries as of December 31, 2015, dated February 25, 2016, included in this Annual Report on Form 10-K of Pacira Pharmaceuticals, Inc. for the year ended December 31, 2015.
/s/ CohnReznick LLP Roseland, New Jersey February 25, 2016 | ||